Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten Jan M Cramer

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
American Journal of Physiology. Renal Physiology|August 4, 2006
Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectorsKim E Jie, Marianne C Verhaar, Maarten-Jan M Cramer, et al.
The International Journal of Cardiovascular Imaging|June 26, 2010
Non-surgical stem cell delivery strategies and in vivo cell tracking to injured myocardiumTycho I G van der Spoel, Joe Chun-Tsu Lee, Krijn Vrijsen, et al.
Journal of Hypertension|June 8, 2018
Four ECG left ventricular hypertrophy criteria and the risk of cardiovascular events and mortality in patients with vascular diseaseMonique E A M van Kleef, Frank L J Visseren, Joris W P Vernooij, et al.
American Heart Journal|May 28, 2019
Smoking cessation and risk of recurrent cardiovascular events and mortality after a first manifestation of arterial diseaseM Johanneke van den Berg, Yolanda van der Graaf, Jaap W Deckers, et al.
International Journal of Cardiology|September 23, 2008
Differences in determinants of left ventricular mass assessed by cardiac magnetic resonance imaging across subjects with and without previous symptomatic atherosclerotic diseaseMatthijs F L Meijs, Michiel L Bots, Maarten-Jan M Cramer, et al.
Journal of Nephrology|April 13, 2010
Erythropoietin treatment in patients with combined heart and renal failure: objectives and design of the EPOCARES studyKarien van der Putten, Kim E Jie, Mireille E Emans, et al.
Journal of Cellular and Molecular Medicine|June 16, 2012
Transendocardial cell injection is not superior to intracoronary infusion in a porcine model of ischaemic cardiomyopathy: a study on delivery efficiencyTycho I G van der Spoel, Krijn R Vrijsen, Stefan Koudstaal, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 4, 2013
The predictive value of the exercise ECG for major adverse cardiac events in patients who presented with chest pain in the emergency departmentJudith M Poldervaart, A Jacob Six, Barbra E Backus, et al.
Clinical Science (London, England : 1979)|December 23, 2011
Inducible cardiac ischaemia is related to a decrease in the whole-blood Toll-like receptor 2 and 4 responseEllen H A M Elsenberg, Dik Versteeg, Jan-Willem Sels, et al.
Molecular Imaging and Biology|April 9, 2010
Characterization and in vitro and in vivo testing of CB2-receptor- and NGAL-targeted paramagnetic micelles for molecular MRI of vulnerable atherosclerotic plaqueBernard C M te Boekhorst, Sandra M Bovens, Juan Rodrigues-Feo, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
American Journal of Physiology. Renal Physiology|August 4, 2006
Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectorsKim E Jie, Marianne C Verhaar, Maarten-Jan M Cramer, et al.
The International Journal of Cardiovascular Imaging|June 26, 2010
Non-surgical stem cell delivery strategies and in vivo cell tracking to injured myocardiumTycho I G van der Spoel, Joe Chun-Tsu Lee, Krijn Vrijsen, et al.
Journal of Hypertension|June 8, 2018
Four ECG left ventricular hypertrophy criteria and the risk of cardiovascular events and mortality in patients with vascular diseaseMonique E A M van Kleef, Frank L J Visseren, Joris W P Vernooij, et al.
American Heart Journal|May 28, 2019
Smoking cessation and risk of recurrent cardiovascular events and mortality after a first manifestation of arterial diseaseM Johanneke van den Berg, Yolanda van der Graaf, Jaap W Deckers, et al.
International Journal of Cardiology|September 23, 2008
Differences in determinants of left ventricular mass assessed by cardiac magnetic resonance imaging across subjects with and without previous symptomatic atherosclerotic diseaseMatthijs F L Meijs, Michiel L Bots, Maarten-Jan M Cramer, et al.
Journal of Nephrology|April 13, 2010
Erythropoietin treatment in patients with combined heart and renal failure: objectives and design of the EPOCARES studyKarien van der Putten, Kim E Jie, Mireille E Emans, et al.
Journal of Cellular and Molecular Medicine|June 16, 2012
Transendocardial cell injection is not superior to intracoronary infusion in a porcine model of ischaemic cardiomyopathy: a study on delivery efficiencyTycho I G van der Spoel, Krijn R Vrijsen, Stefan Koudstaal, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 4, 2013
The predictive value of the exercise ECG for major adverse cardiac events in patients who presented with chest pain in the emergency departmentJudith M Poldervaart, A Jacob Six, Barbra E Backus, et al.
Clinical Science (London, England : 1979)|December 23, 2011
Inducible cardiac ischaemia is related to a decrease in the whole-blood Toll-like receptor 2 and 4 responseEllen H A M Elsenberg, Dik Versteeg, Jan-Willem Sels, et al.
Molecular Imaging and Biology|April 9, 2010
Characterization and in vitro and in vivo testing of CB2-receptor- and NGAL-targeted paramagnetic micelles for molecular MRI of vulnerable atherosclerotic plaqueBernard C M te Boekhorst, Sandra M Bovens, Juan Rodrigues-Feo, et al.
Pageof 4